[RECOMMENDATION] 2018 Oncology Nursing Drug Handbook by Gail M Wilkes Free

Link Download : https://onlinebloggeramazon.blogspot.com/?book=1284143503 Synnopsis : Written especially for nurses caring for patients with cancer, the 2018 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2018 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs. New drugs include: avelumab (Bavencio), brigatinib (Alunbrig), durvalumab (Imfinzi), enasidenib (Idhifa), metronidazole hydrochloride (Flagyl), midostaurin (Rydapt), neratinib (Nerlynx), niraparib (Zejula), olaratumab (Lartruvo), ribociclib (Kisqali), rituximab and hyaluronidase human injection (Rituxan Hycela injection), rucaparib (Rubraca), telotristat ethyl (Xermelo), and tisagenlecleucel (Kymriah). Author : Gail M Wilkes Language : English Grade Level : 1-2 Product Dimensions : 9.5 x 0.5 x 9.4 inches Shipping Weight : 15.8 ounces Format : BOOKS Seller information : Gail M Wilkes ( 6? )
[RECOMMENDATION] 2018 Oncology Nursing Drug Handbook by Gail M Wilkes Free
Written especially for nurses caring for patients with cancer, the 2018 Oncology
Nursing Drug Handbook uniquely expresses drug therapy in terms of the
nursing process: nursing diagnoses, etiologies of toxicities, and key points for
nursing assessment, intervention, and evaluation. Updated annually, this
essential reference provides valuable information on effective symptom
management, patient education, and chemotherapy administration. Completely
revised and updated, the 2018 Oncology Nursing Drug Handbook includes
separate chapters on molecular and immunologic/biologic targeted therapies.
These chapters provide fundamental reviews to assist nurses in understanding
the cellular communication pathways disrupted by cancer. It also offers
simplified content, attention to understanding the immune checkpoint
inhibitors, new information about immunotherapy, new drugs and their
indications, and updated indications and side effects for recently FDA approved
drugs. New drugs include: avelumab (Bavencio), brigatinib (Alunbrig),
durvalumab (Imfinzi), enasidenib (Idhifa), metronidazole hydrochloride
(Flagyl), midostaurin (Rydapt), neratinib (Nerlynx), niraparib (Zejula),
olaratumab (Lartruvo), ribociclib (Kisqali), rituximab and hyaluronidase human
injection (Rituxan Hycela injection), rucaparib (Rubraca), telotristat ethyl
(Xermelo), and tisagenlecleucel (Kymriah).

[Book] [RECOMMENDATION] 2018 Oncology Nursing Drug Handbook by Gail M Wilkes Free
PDF|EPUB|EBOOK|DOC

DETAIL PRODUCT
●
●
●
●
●
●
Author : Gail M Wilkes
Pages : 1712 pages
Publisher : Jones &Bartlett Publishers
Language :
ISBN-10 : 1284143503
ISBN-13 : 9781284143508

DISCRIPSI
Written especially for nurses caring for patients with cancer, the 2018 Oncology Nursing Drug Handbook uniquely expresses drug therapy in
terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation.
Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and
chemotherapy administration. Completely revised and updated, the 2018 Oncology Nursing Drug Handbook includes separate chapters on
molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the
cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint
inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA
approved drugs. New drugs include: avelumab (Bavencio), brigatinib (Alunbrig), durvalumab (Imfinzi), enasidenib (Idhifa), metronidazole
hydrochloride (Flagyl), midostaurin (Rydapt), neratinib (Nerlynx), niraparib (Zejula), olaratumab (Lartruvo), ribociclib (Kisqali), rituximab and
hyaluronidase human injection (Rituxan Hycela injection), rucaparib (Rubraca), telotristat ethyl (Xermelo), and tisagenlecleucel (Kymriah).

DOWNLOAD BOOK
1. Download and stream more than 10,000 movies, e-books,
audiobooks, music tracks, and pictures
2. Adsimple access to all content
3. Quick and secure with high-speed downloads
4. No datalimit
5. Bestseller
6. Free online books of all time

IMAGE BOOK
Read Or Get This Book [RECOMMENDATION] 2018 Oncology Nursing Drug Handbook by Gail M Wilkes
Free , Visit Direct Links by clicking the DOWNLOAD button